Celanese Reports Significant Full-Year Loss and Goodwill Impairment Amidst Challenging Market

summarizeSummary

Celanese reported a substantial full-year 2025 GAAP loss of $10.44 per share, including a $1.1 billion goodwill impairment, and provided cautious Q1 2026 guidance, reflecting ongoing market challenges.

check_boxKey Events

• Full-Year 2025 Performance

  Reported a U.S. GAAP diluted loss per share of $10.44 and adjusted earnings per share of $3.98, with net sales decreasing 7% to $9.5 billion.

• Significant Goodwill Impairment

  Included a $1.1 billion goodwill impairment charge, primarily impacting the Engineered Materials segment, contributing to the substantial GAAP loss.

• Q4 2025 Results

  Posted U.S. GAAP diluted EPS of $0.23 and adjusted EPS of $0.67, with net sales of $2.2 billion, representing a 9% sequential decline.

• Q1 2026 Guidance

  Anticipates adjusted earnings per share between $0.70 and $0.85, indicating continued modest demand and a slight sequential improvement from Q4 2025.

auto_awesomeAnalysis

Celanese Corporation reported a substantial full-year 2025 GAAP diluted loss per share of $10.44, primarily driven by a significant $1.1 billion goodwill impairment charge. Adjusted earnings per share also saw a considerable decline to $3.98 for the year, reflecting a 7% decrease in net sales due to lower prices and volumes. Fourth-quarter results continued this trend with sequential and year-over-year declines in sales and adjusted EPS. The company's Q1 2026 adjusted EPS guidance of $0.70-$0.85 suggests ongoing demand challenges, while the full-year 2026 free cash flow target is slightly below 2025 levels. The impairment charge indicates a re-evaluation of asset values and highlights the difficult operating environment.